FDA — authorised 24 July 1992
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
🇺🇸 Halfan in United States
FDA authorised Halfan on 24 July 1992
Marketing authorisation
Halfan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in United States
Frequently asked questions
Is Halfan approved in United States?
Yes. FDA authorised it on 24 July 1992.
Who is the marketing authorisation holder for Halfan in United States?
GLAXOSMITHKLINE holds the US marketing authorisation.